Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 781

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 2
Chunk 781
---
11) 
     -  
     13,650 
  
    SBA
    EIDL (including accrued interest) (Note 7) 
     8,772  
     8,772 
  
    Derivative Liabilities (Note 8) 
     640,830  
     2,306,796 
  
    Total Current Liabilities 
     1,657,220  
     2,835,424 
  
    Long-Term Liabilities: 

    SBA
    EIDL (including accrued interest) (Note 7) 
     147,119  
     150,251 
  
    Total Long-Term Liabilities 
     147,119  
     150,251 
  
    Total Liabilities 
     1,804,339  
     2,985,675 
  
    Commitments and Contingencies (Note 11) 

    SHAREHOLDERS’ EQUITY: 

    Series A Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; 76,480 and 78,803 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively (Note 6) 
     9,567,439  
     9,858,040 
  
    Common Stock, $0.0001 par value, 150,000,000 shares authorized; 566,908 and 96,847 issued and outstanding as of December 31, 2024 and December 31, 2023, respectively(1) (Note 6) 
     57  
     10 
  
    Additional Paid-in Capital(1) 
     34,860,590  
     27,457,373 
  
    Accumulated Other Comprehensive Income 
     135,471  
     135,561 
  
    Accumulated Deficit 
     (40,527,957) 
     (32,580,850)
  
    60P Shareholders’ Equity: 
     4,035,600  
     4,870,134 
  
    Noncontrolling Interest 
     (80,594) 
     (72,038)
  
    Total Shareholders’ Equity 
     3,955,006  
     4,798,096 
  
    Total